Skip to content
Abierto
Menu

Solicitation, first published as presolicitation

Fluticasone/Salmeterol Inh Powder

36E79726R0009

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Glaxosmithkline, LLC

$0.00 obligated so far on USAspending

Description

As published on SAM.gov.

Amendment issued to correct typo in annual estimates for line item 1 and to extend due date and time for receipt of offers.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Glaxosmithkline, LLC
UEI
FRHTPHMZMX47
CAGE
667E9
Vendor location
Durham, NC
Contract
36E79726D0030
Obligated
$0.00, potential $182,885,824
Actions
2 between May 26, 2026 and August 31, 2026
Competition
Full and Open Competition, 7 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Fluticasone/Salmeterol Inhalers with Glaxosmithkline. Ordering Period Is August 1, 2026 - July 31, 2027 Wit Four ONE-YEAR Options.
Match
solicitation number 36E79726R0009 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. February 2, 2026

    Presolicitation

    Due March 9, 2026 at 3:30 PM EDT. SAM.gov, notice 7ab65a5fb9f74b9c94dcabc522df2e29

  2. February 23, 2026

    Solicitation, originally presolicitation

    Due March 9, 2026 at 3:30 PM EDT. SAM.gov, notice e7c8964170a447d7a7af55ca244a97c3

  3. March 6, 2026

    Solicitation

    Due March 16, 2026 at 3:30 PM EDT. SAM.gov, notice df33a4f83d6a4cb1ab6e39d91b1c56de

  4. March 13, 2026

    Solicitation

    Due March 18, 2026 at 3:30 PM EDT. SAM.gov, notice fcb9d301893045bdb3a03db84ebf8983

Points of contact

Also open from this buyer